[How To]-Nonprofit Foundation-Chesapeake-Researching Type 1 Diabetes
JDRF is the world’s leading charitable funder of type 1 diabetes research and raise money to drive world class research. We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition.
JDRF’s research mission is to discover, develop, and deliver advances that cure, better treat, and prevent T1D. As the global leader in the fight against T1D, JDRF’s research programs are comprehensive – addressing the hopes and dreams of every person with T1D for the best quality of life and a cure for this disease.
Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF works every day to change this by amassing grassroots support, deep scientific knowledge and strong industry and academic partnerships to fund research. Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42293 In 1963, the new independent city of Chesapeake was created when the former independent city of South Norfolk consolidated with Norfolk County. The consolidation, authorized by the Virginia General Assembly, was approved and the new name selected by the voters of each communities by referendum. The new city joined the ranks of the current Seven Cities of Hampton Roads which are linked by the circumferential Hampton Roads Beltway. Formed in 1691 in the Virginia Colony, Norfolk County had originally included essentially all the area which became the towns and later cities of Norfolk, Portsmouth, and South Norfolk, but had seen its area frequently reduced as these cities added territory through annexations after 1871. Becoming an independent city was a method for the former county to stabilize borders with neighbors, as cities could not annex territory from each other. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services In type 1 diabetes, the pancreas, a large gland behind the stomach, stops making insulin because the cells that make the insulin have been destroyed by the body’s immune system. Without insulin, the body’s cells cannot turn glucose (sugar), into energy. People with type 1 diabetes depend on insulin every day of their lives to replace the insulin the body cannot produce. They must test their blood glucose levels several times throughout the day. The onset of type 1 diabetes typically occurs in people under 30 years, but can occur at any age. About 10-15% of all cases of diabetes are type 1. Without insulin the body burns its own fats as a substitute which releases chemical substances in the blood. Without ongoing injections of insulin, the dangerous chemical substances will accumulate and can be life threatening if it is not treated. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
In general, it’s all about:
reality of T1D,Inhaled Insulin,Parents of children with T1D,Clinical Trials,insulin body site rotation,The Walk to Cure Diabetes,TRIAD Results,hypoglycemia,blood glucose level,insulin lispro,hypoglycemic episodes,Encapsulation,Diabetic Ketoacidosis,Afrezza,using insulin,T1D community,T1D patterns,neonatal diabetes,speak out,maturity-onset diabetes of the young,Insulin,juvenile diabetes,ketone,premixed insulin,Blood Glucose Level,World without T1D,ASPIRE Trial,uncontrolled hyperglycemia,blood glucose meter,VLDL cholesterol,Casual Plasma Glucose Test,CDE,preventive therapies,ACCORD Study,Glucagon,Children’s Congress,Oral Glucose Tolerance Test,save a life,Health Care Providers,Medtronic Minimed Insulin Pump Users,Low Blood Sugar,acarabose,acetohexamide,inhaled insulin,Long Acting Insulin,children diabetes,EsTiD,amputation,Regular Acting Insulin,Ride to Cure.